Drug Profile
Research programme: Q fever vaccine - EpiVax
Alternative Names: T cell-driven vaccine candidate - EpiVaxLatest Information Update: 30 May 2022
Price :
$50
*
At a glance
- Originator EpiVax; Massachusetts General Hospital
- Class Antibacterials; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Q fever